Stay updated with breaking news from Oil super majors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to ac ....
The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to ac ....
Pfizer did turn negative late in the day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he e ....
Each week Campaign Brief posts positions available within the Australasian and Asian advertising, media and marketing industry through TheBestAdJobs.com, a joint initiative of Bestads and Campaign Brief. Ads only cost $50 and appear on all CB Blogs (Aust, NZ, Asia) plus internationally on bestadsont ....
Each week Campaign Brief posts positions available within the Australasian and Asian advertising, media and marketing industry through TheBestAdJobs.com, a joint initiative of Bestads and Campaign Brief. Ads only cost $50 and appear on all CB Blogs (Aust, NZ, Asia) plus internationally on bestadsont ....